Ligand Competition Binding Assay for the Androgen Receptor

Methods in Molecular Biology

Volumn 776, Issue , 2011, Pages 59-68

  Féau, Clémentine ^a   Arnold, Leggy A ^a   Kosinski, Aaron ^a   Guy, R Kiplin ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Androgen receptor; endocrine disrupting chemicals; high throughput screening; hormone competition assay; nuclear receptor; scintillation proximity assay

Indexed keywords

ANDROGEN RECEPTOR; LIGAND; RECOMBINANT PROTEIN;

BINDING COMPETITION; ESCHERICHIA COLI; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; METABOLISM; METHODOLOGY; RADIOASSAY; REVIEW;

BINDING, COMPETITIVE; ESCHERICHIA COLI; HUMANS; LIGANDS; MALE; RADIOLIGAND ASSAY; RECEPTORS, ANDROGEN; RECOMBINANT PROTEINS;

EID: 80052952709     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-243-4_4     Document Type: Chapter

References (24)

1. Chang C (2002) Androgens and androgen receptor: mechanisms, functions, and clinical applications. Kluwer: Norwell.
2. Gray LE, Ostby J, Furr J et al (2001) Effects of environmental antiandrogens on reproductive development in experimental animals. Hum Reprod Update 7(3):248–64.
3. Kelce WR, Monosson E, Gamcsik MP et al (1994) Environmental hormone dis-ruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol 126(2): 276–85.
4. ′-DDE is a potent androgen receptor antagonist. Nature 375(6532):581–5.
5. Seftel A (2005) Comparison of the pharmacological effects of a novel selective androgen receptor modulator (SARM), the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia (BPH). J Urol 173(4):1279.
6. Iversen P, Wirth MP, See WA et al (2004) Is the efficacy of hormonal therapy affected by lymph node status? Data from the bicalutamide (Casodex) Early Prostate Cancer program. Urology 63(5):928–33.
7. Liao M, Wilson EM (2001) Production and purification of histidine-tagged dihydrotestosterone-bound full-length human androgen receptor. Methods Mol Biol 176:67–79.
8. Breiner M, Romalo G, Schweikert HU (1986) Inhibition of androgen receptor binding by natural and synthetic steroids in cultured human genital skin fibroblasts. Klin Wochenschr 64(16):732–7.
9. Sonnenschein C, Olea N, Pasanen ME et al (1989) Negative controls of cell proliferation: human prostate cancer cells and androgens. Cancer Res 49(13):3474–81.
10. Schoonen WG, Deckers G, de Gooijer ME et al (2000) Contraceptive progestins. Various 11-substituents combined with four 17-substituents: 17alpha-ethynyl, five-and six-membered spiromethylene ethers or six-membered spiromethylene lactones. J Steroid Biochem Mol Biol 74(3):109–23.
11. Bauer ER, Daxenberger A, Petri T et al (2000) Characterisation of the affinity of different anabolics and synthetic hormones to the human androgen receptor, human sex hormone binding globulin and to the bovine progestin receptor. Apmis 108(12):838–46.
12. Matias PM, Donner P, Coelho R et al (2000) Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J Biol Chem 75(4):26164–71.
13. Roehrborn CG, Zoppi S, Gruber J A et al (1992) Expression and characterization of full-length and partial human androgen receptor fusion proteins. Implications for the production and applications of soluble steroid receptors in Escherichia coli. Mol Cell Endocrinol 84 (1–2):1–14.
14. Juzumiene D, Chang CY, Fan D et al (2005) Single-step purification of full-length human androgen receptor. Nucl Recept Signal 3:e001.
15. Quarmby VE, Kemppainen JA, Sar M et al (1990) Expression of recombinant androgen receptor in cultured mammalian cells. Mol Endocrino 4(9):1399–407.
16. Bauer ER, Bitsch N, Brunn H et al (2002) Development of an immuno-immobilized androgen receptor assay (IRA) and its application for the characterization of the receptor binding affinity of different pesticides. Chemosphere 46(7):1107–15.
17. Fang H, Tong W, Branham WS et al (2003) Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. Chem Res Toxicol 16(10): 1338–58.
18. Yamasaki K, Sawaki M, Noda S et al (2004) Comparison of the Hershberger assay and androgen receptor binding assay of twelve chemicals. Toxicology 195(2–3):177–86.
19. Freyberger A, Ahr HJ (2004) Development and standardization of a simple binding assay for the detection of compounds with affinity for the androgen receptor. Toxicology 195 (2–3):113–26.
20. Nichols JS, Parks DJ, Consler TG et al (1998) Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain. Anal Biochem 257(2):112–9.
21. Janowski BA, Grogan MJ, Jones SA et al (1999) Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ. Proc Natl Acad Sci 96: 266–71.
22. Allan GF, Hutchins A, Clancy J (1999) An ultrahigh-throughput screening assay for estrogen receptor ligands. Anal Biochem 275(2):243–7.
23. Wu B, Gao J, Wang M (2005) Development of a complex scintillation proximity assay for high-throughput screening of PPARγ modulators. Acta Pharma Sinica 26(3):339–44.
24. Feau C, Arnold L A, Kosinski A, Guy RK (2009) A high-throughput ligand competition binding assay for the androgen receptor and other nuclear receptors. JBS 14(1): 43–48.